Ildong Holdings Co Ltd (000230) - Total Liabilities
Based on the latest financial reports, Ildong Holdings Co Ltd (000230) has total liabilities worth ₩445.36 Billion KRW (≈ $301.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Ildong Holdings Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Ildong Holdings Co Ltd - Total Liabilities Trend (1999–2025)
This chart illustrates how Ildong Holdings Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Ildong Holdings Co Ltd's balance sheet.
Ildong Holdings Co Ltd Competitors by Total Liabilities
The table below lists competitors of Ildong Holdings Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CTI Traffic Industries Co Ltd
TWO:2230
|
Taiwan | NT$695.62 Million |
|
PB Bankshares Inc
NASDAQ:PBBK
|
USA | $405.08 Million |
|
Element 25 Ltd
AU:E25
|
Australia | AU$7.16 Million |
|
Softcat plc
LSE:SCT
|
UK | GBX919.96 Million |
|
Bengang Steel Plates Co Ltd
SHE:200761
|
China | HK$40.10 Billion |
|
Cj Seafood
KO:011150
|
Korea | ₩80.91 Billion |
|
Greatland Resources Limited
LSE:GGP
|
UK | GBX371.74 Million |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩72.55 Billion |
Liability Composition Analysis (1999–2025)
This chart breaks down Ildong Holdings Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Ildong Holdings Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ildong Holdings Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ildong Holdings Co Ltd (1999–2025)
The table below shows the annual total liabilities of Ildong Holdings Co Ltd from 1999 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩457.28 Billion ≈ $309.89 Million |
-23.88% |
| 2024-12-31 | ₩600.70 Billion ≈ $407.09 Million |
-15.05% |
| 2023-12-31 | ₩707.10 Billion ≈ $479.19 Million |
+1.97% |
| 2022-12-31 | ₩693.45 Billion ≈ $469.94 Million |
-5.96% |
| 2021-12-31 | ₩737.42 Billion ≈ $499.74 Million |
+49.34% |
| 2020-12-31 | ₩493.79 Billion ≈ $334.63 Million |
+1.91% |
| 2019-12-31 | ₩484.53 Billion ≈ $328.36 Million |
+382.01% |
| 2018-12-31 | ₩100.52 Billion ≈ $68.12 Million |
+0.32% |
| 2017-12-31 | ₩100.20 Billion ≈ $67.91 Million |
+3.04% |
| 2016-12-31 | ₩97.25 Billion ≈ $65.90 Million |
-72.66% |
| 2015-12-31 | ₩355.66 Billion ≈ $241.02 Million |
+23.75% |
| 2014-12-31 | ₩287.40 Billion ≈ $194.76 Million |
-4.71% |
| 2013-12-31 | ₩301.61 Billion ≈ $204.40 Million |
+38.80% |
| 2012-12-31 | ₩217.30 Billion ≈ $147.26 Million |
+7.85% |
| 2011-12-31 | ₩201.48 Billion ≈ $136.54 Million |
-14.71% |
| 2010-12-31 | ₩236.23 Billion ≈ $160.09 Million |
+9.74% |
| 2009-12-31 | ₩215.26 Billion ≈ $145.88 Million |
+8.76% |
| 2008-12-31 | ₩197.93 Billion ≈ $134.13 Million |
+41.10% |
| 2007-12-31 | ₩140.28 Billion ≈ $95.06 Million |
+26.62% |
| 2006-12-31 | ₩110.78 Billion ≈ $75.08 Million |
-0.45% |
| 2005-12-31 | ₩111.29 Billion ≈ $75.42 Million |
+3.78% |
| 2004-12-31 | ₩107.23 Billion ≈ $72.67 Million |
-5.20% |
| 2003-12-31 | ₩113.11 Billion ≈ $76.65 Million |
+11.93% |
| 2002-12-31 | ₩101.06 Billion ≈ $68.49 Million |
-2.59% |
| 2001-12-31 | ₩103.74 Billion ≈ $70.31 Million |
-14.10% |
| 2000-12-31 | ₩120.77 Billion ≈ $81.84 Million |
-9.20% |
| 1999-12-31 | ₩133.00 Billion ≈ $90.13 Million |
-- |
About Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more